Advisory Agreements in the Health Care Equipment & Supplies Industry
16 Contracts & Agreements
- Arch Therapeutics, Inc. (1 contract)
- Bellerophon Therapeutics, Inc. (1)
- Hancock Jaffe Laboratories, Inc. (5)
- HealthCor Catalio Acquisition Corp. (1)
- IDEXX Laboratories (2)
- Longview Acquisition Corp. (1)
- OZOP SURGICAL CORP. (1)
- Precision Therapeutics Inc. (1)
- ROCKWELL MEDICAL, INC. (1)
- Stereotaxis, Inc. (1)
- TearLab Corp (1)
- Advisory Agreement, dated as of December 22, 2021, by and between Hyperfine, Inc. and Dr. Jonathan M. Rothberg (HealthCor Catalio Acquisition Corp., Filed With SEC on December 28, 2021)
- Advisory Agreement between Ozop Capital and RMA dated September 1, 2021 (OZOP SURGICAL CORP., Filed With SEC on September 2, 2021)
- Advisory Agreement, dated as of February 12, 2021, by and between Butterfly Network, Inc. and Jonathan Rothberg, Ph.D (Longview Acquisition Corp., Filed With SEC on March 29, 2021)
- Advisory Agreement, by and between Bellerophon Therapeutics, Inc. and Angel Pond Capital LLC, dated May 18, 2020 (Bellerophon Therapeutics, Inc., Filed With SEC on May 20, 2020)
- Amendment to Senior Advisory Agreement, dated April 14, 2020, by and between the Company and Mr. Jonathan W. Ayers (IDEXX Laboratories, Filed With SEC on April 30, 2020)
- Senior Advisory Agreement, dated October 23, 2019, by and between IDEXX Laboratories Inc. and Mr. Jonathan W. Ayers (IDEXX Laboratories, Filed With SEC on October 24, 2019)
- Advisory Agreement, effective July 19, 2018, by and between Arch Therapeutics, Inc. and Dr. Avtar Dhillon (Arch Therapeutics, Inc., Filed With SEC on July 20, 2018)
- Medical Advisory Board Agreement, dated as of October 1, 2016, by and between the Registrant and Afksendyios Kalangos, M.D (Hancock Jaffe Laboratories, Inc., Filed With SEC on November 6, 2017)
- Medical Advisory Board Agreement, dated as of May 1, 2016, by and between the Registrant and Steve Elias, M.D (Hancock Jaffe Laboratories, Inc., Filed With SEC on September 7, 2017)
- Medical Advisory Board Agreement, dated as of May 1, 2016, by and between the Registrant and Antonios Gasparis (Hancock Jaffe Laboratories, Inc., Filed With SEC on September 7, 2017)
- Medical Advisory Board Agreement, dated as of September 1, 2016, by and between the Registrant and Wade Dimitri, M.D (Hancock Jaffe Laboratories, Inc., Filed With SEC on September 7, 2017)
- Medical Advisory Board Agreement, dated as of October 1, 2016, by and between the Registrant and Mark Meissner, M.D (Hancock Jaffe Laboratories, Inc., Filed With SEC on September 7, 2017)
- Eric N. Prystowsky, MD STEREOTAXIS ADVISORY BOARD AND CONSULTINGAGREEMENT (Stereotaxis, Inc., Filed With SEC on May 6, 2011)
- Letter Agreement, dated January 8, 2010, amending the Capital Advisory Agreement with Greybrook Capital Inc (TearLab Corp, Filed With SEC on January 11, 2010)
- Advisory Agreement (ROCKWELL MEDICAL, INC., Filed With SEC on August 12, 2008)
- ADVISORY AGREEMENT (Precision Therapeutics Inc., Filed With SEC on August 24, 2007)